Anchor Investment Management’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.03K Hold
58
﹤0.01% 879
2025
Q4
$5.98K Hold
58
﹤0.01% 879
2025
Q3
$5.24K Hold
58
﹤0.01% 898
2025
Q2
$5.1K Hold
58
﹤0.01% 887
2025
Q1
$5.29K Hold
58
﹤0.01% 873
2024
Q4
$5K Hold
58
﹤0.01% 880
2024
Q3
$5.51K Hold
58
﹤0.01% 866
2024
Q2
$5.31K Hold
58
﹤0.01% 837
2024
Q1
$5.26K Hold
58
﹤0.01% 859
2023
Q4
$4.72K Hold
58
﹤0.01% 821
2023
Q3
$4.63K Hold
58
﹤0.01% 837
2023
Q2
$4.57K Hold
58
﹤0.01% 838
2023
Q1
$4.5K Hold
58
﹤0.01% 845
2022
Q4
$4.51K Hold
58
﹤0.01% 809
2022
Q3
$3.9K Hold
58
﹤0.01% 832
2022
Q2
$4.46K Hold
58
﹤0.01% 825
2022
Q1
$4.63K Hold
58
﹤0.01% 853
2021
Q4
$4.46K Hold
58
﹤0.01% 881
2021
Q3
$4.22K Hold
58
﹤0.01% 800
2021
Q2
$4.24K Hold
58
﹤0.01% 822
2021
Q1
$4K Hold
58
﹤0.01% 806
2020
Q4
$3.85K Hold
58
﹤0.01% 783
2020
Q3
$3.61K Hold
58
﹤0.01% 760
2020
Q2
$3.61K Hold
58
﹤0.01% 740
2020
Q1
$3.15K Hold
58
﹤0.01% 729
2019
Q4
$3.72K Hold
58
﹤0.01% 730
2019
Q3
$3.31K Hold
58
﹤0.01% 727
2019
Q2
$3.4K Hold
58
﹤0.01% 717
2019
Q1
$3.52K Hold
58
﹤0.01% 714
2018
Q4
$3.18K Hold
58
﹤0.01% 732
2018
Q3
$3.73K Hold
58
﹤0.01% 748
2018
Q2
$3.42K Hold
58
﹤0.01% 767
2018
Q1
$3.3K Hold
58
﹤0.01% 741
2017
Q4
$3.44K Buy
+58
New +$3.33K ﹤0.01% 742

Other funds holding PPH

Anchor Investment Management's PPH Position: Q1 2026 in Review

Anchor Investment Management held its VanEck Pharmaceutical ETF (PPH) position steady in Q1 2026 at 58 shares worth $6.03K. The position accounts for ﹤0.01% of the portfolio, ranked #879.

Anchor Investment Management first reported a position in PPH in Q4 2017 and has held it in 34 quarters since. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Anchor Investment Management held 58 shares of VanEck Pharmaceutical ETF worth $6.03K as of Q1 2026.
  • Anchor Investment Management left its VanEck Pharmaceutical ETF share count unchanged in Q1 2026.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Anchor Investment Management's portfolio in Q1 2026, its #879 holding.
  • Anchor Investment Management first reported a position in VanEck Pharmaceutical ETF in Q4 2017 and has held it in 34 quarters since.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Anchor Investment Management's 13F filing for Q1 2026, filed 1 May 2026.